Fibroblast‐growth‐factor‐23 in heart failure with preserved ejection fraction: relation to exercise capacity and outcomes

AIMS: This study aimed to assess plasma fibroblast growth factor 23 (FGF23) in patients with heart failure with preserved ejection fraction (HFpEF) and its relation to inflammation, renal function, clinical and imaging characteristics, exercise capacity, and prognosis. METHODS AND RESULTS: We perfor...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:ESC Heart Fail
Auteurs principaux: Kanagala, Prathap, Arnold, Jayanth R., Khan, Jamal N., Singh, Anvesha, Gulsin, Gaurav S., Eltayeb, Mohamed, Gupta, Pankaj, Squire, Iain B., McCann, Gerry P., Ng, Leong L.
Format: Artigo
Langue:Inglês
Publié: John Wiley and Sons Inc. 2020
Sujets:
Original Research Articles
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC7755022/
https://ncbi.nlm.nih.gov/pubmed/32935918
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ehf2.13020
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires